Neoplasms: all 9,610 studies
Page 18 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered CancerRecruitingNCT05904457Phase 2
- Patient Recorded Indexing MeasurementsRecruitingNCT05899205
- A Study of SHR-A1811 in Subjects With Gynaecologic OncologyRecruitingNCT05896020Phase 2
- A Study of EOC237 in Patients With Advanced Solid TumorRecruitingNCT05895825Phase 1
- HPV-T in HPV-16 Positive Recurrent or Metastatic Solid TumorsRecruitingNCT05895370Phase 1
- T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaRecruitingNCT05894824Phase 1/2
- TQB2223 Injection in Combination With Penpulimab in Patients With Advanced CancersRecruitingNCT05894421Phase 1
- Metal-ions in Patients With the PEEK HD Coupling Mechanism of the KneeNot yet recruitingNCT05893602
- 68Ga-P3 PET/CT Imaging in MalignancyRecruitingNCT05887687Not applicable
- Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid TumorsRecruitingNCT05886868Phase 1
- A Study of HMPL-415S1 in Patients With Advanced Malignant Solid TumorsRecruitingNCT05886374Phase 1
- Impact of Gonadotoxic Therapies on FertilityRecruitingNCT05885048
- Phase I Study of QLS1103 in Subjects With Advanced Solid TumorsRecruitingNCT05884801Phase 1
- Asian Myeloproliferative Neoplasm (MPN) RegistryRecruitingNCT05882773
- Goal Concordant Care Learning LaboratoryEnrolling by invitationNCT05879211Not applicable
- Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical StudyRecruitingNCT05879146Phase 2
- A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.RecruitingNCT05877924Phase 1
- Study of ZG0895.HCl in Patients With Advanced Solid TumorsRecruitingNCT05877664Phase 1
- Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic CancerRecruitingNCT05877430Phase 1/2
- Ovarian Tissue Cryopreservation for Fertility PreservationRecruitingNCT05875155
- uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoRecruitingNCT05874921
- Role of the Gut Microbiome in Anti-tumor Therapy Induced DiarrheaRecruitingNCT05873231
- Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)RecruitingNCT05872867Phase 1
- Palliative Care and Oncology Survey on TerminologyRecruitingNCT05871996
- BPB-101 in Subjects With Metastatic or Locally Advanced Solid TumorsRecruitingNCT05869240Phase 1/2
- A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant TumorsRecruitingNCT05868876Phase 1
- Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid TumorsRecruitingNCT05868174Phase 1
- Clinical Trial Evaluating the Safety of the TQB2103 for InjectionRecruitingNCT05867563Phase 1
- Fit to Fight Childhood CancerRecruitingNCT05867186
- Discontinuation StudyRecruitingNCT05866757Not applicable
- A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid TumorsRecruitingNCT05866692Phase 1
- Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid TumorsEnrolling by invitationNCT05865925Phase 1/2
- Clinical Study of PM1003 in Phase I/IIa Treatment of Advanced Malignant Solid TumorsRecruitingNCT05862831Phase 1/2
- A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored StudyRecruitingNCT05862285Phase 3
- A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced MalignanciesRecruitingNCT05862259
- Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)RecruitingNCT05859659
- A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerRecruitingNCT05859074Phase 1
- Impact of a Multidisciplinary End-of-treatment Day Hospital on the Quality of Life of Adolescents and Young Adults With CancerRecruitingNCT05858424Not applicable
- COrSIcA: Disease MeasurementNot yet recruitingNCT05858021
- Ex Vivo Drug Sensitivity Testing and Multi-Omics ProfilingRecruitingNCT05857969Phase 1
- Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid TumorsRecruitingNCT05856981Phase 1
- Postoperative Effects of Different Enterostomy ApproachesRecruitingNCT05853094Not applicable
- Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell LymphomaRecruitingNCT05852717Phase 2
- Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant TumorsRecruitingNCT05851092Phase 1
- 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade GliomasNot yet recruitingNCT05850377
- UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid TumorsRecruitingNCT05848999Phase 1
- 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese PatientsRecruitingNCT05847348Phase 3
- Resilience Mobile App for Teens and Young Adults With CancerRecruitingNCT05842902Not applicable
- Improved Diagnosis of Ovarian CancerRecruitingNCT05842629
- Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies.RecruitingNCT05841771Phase 2
- Study of IMX-110 in Combination With Tislelizumab in Patients With Advanced Solid TumorsRecruitingNCT05840835Phase 1/2
- Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)RecruitingNCT05839717
- Serious Gaming for Chemotherapy-induced Nausea and VomitingRecruitingNCT05838638Not applicable
- A Study of IMC008 for Advanced Solid TumorsRecruitingNCT05837299Phase 1
- A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting Chimeric Antigen Receptor (CAR) T-cells in Patients With Relapsed and Refractory B-cell MalignanciesRecruitingNCT05836896Phase 1
- Integrin αvβ6-targeted PET in Malignant TumorsRecruitingNCT05835570
- Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer CenterRecruitingNCT05833165
- ONLOOP Trial: Evaluating a New Surveillance and Support System for Survivors of Childhood Cancer in OntarioNot yet recruitingNCT05832138Not applicable
- Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain TumorsRecruitingNCT05831631
- Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer PatientsRecruitingNCT05830929Not applicable
- A Phase I Study of QLP2117 in Subjects With Advanced Solid TumorsRecruitingNCT05830045Phase 1
- A Phase I Study of QLS12004 in Patients With Advanced Solid TumorsNot yet recruitingNCT05829616Phase 1
- Improving Health Insurance Literacy Among Young Adult Cancer SurvivorsRecruitingNCT05829070Not applicable
- First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid TumorsRecruitingNCT05828459Phase 1
- CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic DiseasesRecruitingNCT05827835Phase 1/2
- A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)RecruitingNCT05824975Phase 1/2
- Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint InhibitorsNot yet recruitingNCT05824494Phase 2
- JYB1907 in Subjects With Advanced Solid TumorsNot yet recruitingNCT05821595Phase 1
- A Study of SHR-4602 in Subjects With Advanced Malignant Solid TumorsRecruitingNCT05819684Phase 1
- KSX01-TCRT Injection Project in Solid TumorsRecruitingNCT05811975Early Phase 1
- Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.RecruitingNCT05808634Phase 1
- Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid MalignanciesRecruitingNCT05807659Phase 2
- Autologous Tumour Vaccine TrialRecruitingNCT05807035Phase 1
- Comprehensive Tobacco Cessation for Cancer Patients and SurvivorsRecruitingNCT05805722Not applicable
- A Study of KM501 in Patients With Solid TumorsNot yet recruitingNCT05804864Phase 1
- The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection StudyRecruitingNCT05804331
- MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)RecruitingNCT05802069
- PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid TumorRecruitingNCT05801237Phase 1/2
- JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer PatientsRecruitingNCT05800535
- A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard TherapyRecruitingNCT05798026Phase 1
- Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer SurveillanceRecruitingNCT05796375Phase 2
- A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid TumorsRecruitingNCT05794477Phase 1/2
- Early Intervention to Prevent Lower Limb Lymphedema of Gynecological MalignancyRecruitingNCT05793749Not applicable
- Thymalfasin-based PRaG Mode for Advanced Refractory Solid TumorsRecruitingNCT05790447Phase 2
- A Study of BPI-460372 in Advanced Solid Tumor PatientsRecruitingNCT05789602Phase 1
- DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsRecruitingNCT05786716Phase 2/3
- Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid CancerRecruitingNCT05783323Phase 2
- MSLN-targeted CAR-T Cells in Solid Tumors.Not yet recruitingNCT05783089Phase 1
- Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNsRecruitingNCT05782985
- Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant TumorsRecruitingNCT05781555Not applicable
- Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric OncologyRecruitingNCT05781295Not applicable
- Multi-Cancer Early Detection (MCED) of FirefightersRecruitingNCT05780957
- The Effects of Multi-Psycho-Oncology Care CoursesRecruitingNCT05776680Not applicable
- A Clinical Study of 9MW2821 in Advanced Malignant Solid TumorsRecruitingNCT05773937Phase 1
- A Study of XZB-0004 in Patients With Solid TumorsRecruitingNCT05772455Phase 1
- DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.RecruitingNCT05770544Phase 2/3
- DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) DispositionRecruitingNCT05770102Phase 2/3
- DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive CancersRecruitingNCT05770037Phase 2/3
- A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 AlterationsRecruitingNCT05769075Phase 1
- Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal NeoplasiaRecruitingNCT05768282Phase 4